Doctor profile · Federal record
Dr. MOSHE HIRTH, M.D.
Gastroenterology Physician (CMS: GASTROENTEROLOGY) · DELRAY BEACH, FL
- NPI 1740374677
- Accepts Medicare
- MIPS 84.5 / 100 · 2023
- 38 yrs in practice
- Male
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
6646 ATLANTIC AVE STE 100
DELRAY BEACH, FL 334461627
(561) 638-9533
fax (561) 638-7760
Credentials & registration
- NPI registered
- October 2006 — 20 yrs on file
- Profile last updated
- March 31, 2021
- Year of graduation
- 1988 — 38 yrs since
- Specialty taxonomy
- 207RG0100X — NUCC code
- State license (1)
- Florida #ME0064286
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1740374677. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
51,074
Distinct HCPCS
10
Medicare allowed
$1,645,213
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J3380 |
Injection, vedolizumab, 1 mg | 46,200 | 30 | $22 | |
43239 |
Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 663 | 529 | $92 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 530 | 438 | $92 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 529 | 442 | $130 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 399 | 399 | $171 | |
U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 278 | 266 | $74 | |
U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within | 278 | 266 | $25 | |
46221 |
Removal of external hemorrhoids by rubber banding | 256 | 91 | $293 | |
96413 |
Administration of chemotherapy into vein, 1 hour or less | 176 | 33 | $132 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 175 | 164 | $58 |
In context: peer comparison
Among 4 peers in this city , average services per provider: 974. This provider delivers 52× the peer median.Open Payments
Industry payments received
All-time total
$395
Transactions
18
Manufacturers
7
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Janssen Biotech, Inc. | 6 | $122.31 | |
| ABBVIE INC. | 5 | $115.12 | |
| Gilead Sciences, Inc. | 3 | $86.51 | |
| Intercept Pharmaceuticals, Inc. | 1 | $21.23 | |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20.44 | |
| PFIZER INC. | 1 | $15.50 | |
| VIVUS LLC | 1 | $14.27 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
2,358
Patients
1,372
Total drug cost
$165,385
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Pantoprazole Sodium | Generic | 1,301 | 639 | $20,499 |
| Famotidine | Generic | 296 | 152 | $4,112 |
| Sutab (Sod Sulf/Pot Chloride/Mag Sulf) | Brand | 194 | 186 | $32,449 |
| Hydrocortisone | Generic | 87 | 75 | $1,488 |
| Dicyclomine Hcl | Generic | 81 | 49 | $1,299 |
| Clenpiq (Sod Picosulf/Mag Ox/Citric Ac) | Brand | 58 | 57 | $10,264 |
| Omeprazole | Generic | 58 | 31 | $951 |
| Linzess (Linaclotide) | Brand | 52 | 22 | $47,278 |
| Gavilyte-G (Peg3350/Sod Sulf,bicarb,cl/Kcl) | Brand | 39 | 39 | $650 |
| Mesalamine | Generic | 37 | 12 | $27,812 |